Blood Preparation Market report is segmented on the basis of type, application, and regional& country level. Based upon type, market is classified as whole blood, blood components, and blood derivatives. Based upon application market is classified into thrombocytosis, pulmonary embolism, renal impairment, angina blood vessel complications, others.
The Blood Preparation Market is valued at USD 70.10 Billion in 2021 and is expected to reach USD 89.80 Billion by 2028 with a CAGR of 3.6% over the forecast period.
The entire blood which is a mixture of cells, colloids and crystalloids can be separated into different blood components namely packed red blood cell (PRBC) concentrate, platelet concentrate, fresh frozen plasma and cryoprecipitate. Each blood element is employed for a distinct indication; so the element separation has maximized the utility of 1blood unit. Whole human blood collected from a donor and processed either for transfusion or for additional producing. Blood component means a therapeutic constituent of human blood that can be prepared by various methods. Whole blood element Formulation offers 2 main styles of technology: living substance wealthy plasma and buffy coat, both of which are driven by platelet production. It is estimated that a total collection of 112.5 million blood donations were made in the 180 countries during the reporting period. Of these, 100.6 million were whole blood donations and 11.9 million were apheresis donations
The regions covered in this Global Blood Preparation market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Blood Preparation is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Blood Preparation market Report covers prominent players are like -
Rise in the worldwide demand for transfusion of blood due to increasing prevalence of blood related disorders has driven blood preparation market. The growing geriatric population base which is more susceptible to such disorders is one of the major factors driving the industry trends. Blood Formulation industry is gaining considerable traction with the increasing government initiatives to spread awareness pertaining to blood disorders. Also, exchanging demographics will also donate to greater healthcare spending; this is often possible to continue with the size of the elderly population set to rise from the current 98.9 million to about 168 million by 2026. Rising demand of blood for surgical procedures, increasing number of cardiac surgeries in developed and developing economies are key factors driving growth of the global market. High risk of transmission of disease such viral fever; HIV is a key factor hampering the growth of the global Market. The growing demand for cause plasma and the need for specific plasma components such as crowded red plasma cells will create new growth opportunities for the market.
North America is expected to drive the blood preparation market. Within the United States, there are about 8 million voluntary donors per year who contributed to plasma donation. Development timelines for pathogen-reduced cryoprecipitate are tracking to plan and we are planning to submit for U.S. regulatory approval in the second half of 2019, which could set the stage for potential U.S. approval and commercialization in 2020. Asia Pacific is also anticipated to witness high growth in future, owing to the presence of favorable government initiatives, cultured healthcare infrastructure, especially in Japan and Australia, and several untapped opportunities in the emerging markets of China and India.
Report Analysis | Details |
---|---|
Historical data | 2015 - 2020 |
Forecast Period | 2021 - 2028 |
Market Size in 2021: | USD 70.10 Billion |
Base year considered | 2020 |
Forecast Period CAGR %: |
3.6% |
Market Size Expected in 2028: | USD 89.80 Billion |
Tables, Charts & Figures: | 175 |
Pages | 200 |
Companies | Abbott Laboratories, Braun Melsungen AG, Bio-Rad Laboratories, CSL Behring, Fenwal, Inc., Fresenius Kabi, Grifols, Haemonetics Corporation, Hologic, Inc., Immucor, Inc., MacoPharma, Octapharma AG, Roche Diagnostics, Terumo Corporation, Thermo Fisher Scientific, Others |
Segments Covered | By Type, By Application |
Regional Analysis | North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®